Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2025-12-26 @ 12:24 AM
NCT ID: NCT05940194
Description: None
Frequency Threshold: 5
Time Frame: - 7 days after each vaccination for solicited AEs - 28 days after each vaccination for unsolicited AEs - From first vaccination to Day 197 for AE of special interest (AESIs) and SAE
Study: NCT05940194
Study Brief: NDV-HXP-S Vaccine Clinical Trial (COVIVAC)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
COVIVAC 3 mcg 3 mcg IVAC COVIVAC vaccine for intramuscular injection administered as two doses (0.5mL each) 28 days apart. COVIVAC vaccine: For prevention Covid-19 0 None 5 124 25 124 View
COVIVAC 6 mcg 6 mcg IVAC COVIVAC vaccine for intramuscular injection administered as two doses (0.5mL each) 28 days apart. COVIVAC vaccine: For prevention Covid-19 0 None 3 125 22 125 View
AZD1222 AZD1222 (AstraZeneca) vaccine for intramuscular injection administered as two doses (0.5mL each) 28 days apart. COVIVAC vaccine: For prevention Covid-19 0 None 0 125 25 125 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
STOMACH CANCER SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (10.0) View
COVID-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (10.0) View
COLON CANCER SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (10.0) View
LEUKEMIA SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (10.0) View
INTESTINAL OBSTRUCTION SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
CHRONIC INFLAMMATION OF THE SALIVARY GLANDS SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (10.0) View
INFECTION AFTER SURGERY SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (10.0) View
BRAIN CONCUSSION (DUE TO TRAFFIC ACCIDENT) SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (10.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Covid-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (10.0) View